Your browser is no longer supported. Please, upgrade your browser.
Settings
NVAX Novavax, Inc. daily Stock Chart
NVAX [NASD]
Novavax, Inc.
Index- P/E- EPS (ttm)-0.91 Insider Own0.50% Shs Outstand296.15M Perf Week-4.81%
Market Cap293.19M Forward P/E- EPS next Y-0.59 Insider Trans17.08% Shs Float278.12M Perf Month19.42%
Income-246.60M PEG- EPS next Q-0.16 Inst Own50.10% Short Float20.95% Perf Quarter-39.26%
Sales16.80M P/S17.45 EPS this Y-72.80% Inst Trans-4.65% Short Ratio8.94 Perf Half Y-23.26%
Book/sh-0.11 P/B- EPS next Y4.80% ROA-56.70% Target Price3.48 Perf Year-82.38%
Cash/sh0.71 P/C1.39 EPS next 5Y0.00% ROE-787.40% 52W Range0.73 - 8.49 Perf YTD-21.43%
Dividend- P/FCF- EPS past 5Y-43.40% ROI- 52W High-88.34% Beta1.97
Dividend %- Quick Ratio4.60 Sales past 5Y0.90% Gross Margin- 52W Low35.62% ATR0.08
Employees355 Current Ratio4.60 Sales Q/Q35.70% Oper. Margin- RSI (14)49.17 Volatility8.16% 9.17%
OptionableYes Debt/Eq- EPS Q/Q44.10% Profit Margin- Rel Volume0.67 Prev Close1.04
ShortableYes LT Debt/Eq- EarningsMay 08 AMC Payout- Avg Volume6.52M Price0.99
Recom2.70 SMA206.75% SMA50-1.54% SMA200-53.25% Volume4,353,676 Change-4.81%
Sep-20-16Reiterated Chardan Capital Markets Neutral $5.75 → $1.50
Sep-16-16Reiterated FBR & Co. Outperform $17 → $12
Sep-16-16Downgrade Wedbush Outperform → Neutral $14 → $2
Sep-16-16Downgrade Piper Jaffray Overweight → Neutral
Sep-16-16Downgrade Ladenburg Thalmann Buy → Neutral
Sep-16-16Downgrade JP Morgan Overweight → Neutral
Sep-16-16Downgrade Citigroup Buy → Neutral
Apr-04-16Initiated Chardan Capital Markets Neutral $5.75
Jul-09-15Reiterated Citigroup Buy $10 → $18
Jun-09-15Initiated Guggenheim Buy
Mar-11-14Reiterated Ladenburg Thalmann Buy $4 → $10
Oct-30-13Initiated FBR Capital Outperform $11
Sep-25-13Reiterated MLV & Co Buy $8.50 → $9.50
Mar-15-11Initiated Wedbush Outperform $6
Jun-15-10Initiated Dawson James Buy $4.50
Mar-15-10Initiated Roth Capital Buy $5
Dec-03-09Initiated Global Hunter Securities Buy $7.25
Dec-01-09Initiated Piper Jaffray Overweight $4.50
Nov-05-09Initiated Merriman Buy $7
Sep-02-09Downgrade Oppenheimer Outperform → Perform
May-26-17 07:06AM  Can The Uptrend Continue for Novavax (NVAX)? Zacks
May-22-17 01:58PM  ETFs with exposure to Novavax, Inc. : May 22, 2017 Capital Cube
May-19-17 08:00AM  Today's Research Reports on Biotech Stocks to Watch: Novavax and Progenics Pharmaceuticals Accesswire
May-18-17 08:00AM  Novavax Financial Review, Analysts Target and Outlook Accesswire +5.83%
May-16-17 09:34AM  Biotech Movers: Akebia, Editas, Novavax TheStreet.com
08:08AM  Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : May 16, 2017 Capital Cube
May-15-17 12:12PM  Here's What's Driving Up Novavax, Inc. Stock Again Today Motley Fool +9.00%
May-13-17 11:15PM  Edited Transcript of NVAX earnings conference call or presentation 8-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-11-17 05:16PM  ETFs with exposure to Novavax, Inc. : May 11, 2017 Capital Cube +10.93%
05:16PM  Here's What Is Pushing Up Novavax, Inc. Stock Today Motley Fool
08:07AM  Novavax Announces the Promotion of Dr. James F. Cummings to Vice President, Clinical Development and Translational Medicine GlobeNewswire
May-10-17 10:11AM  Novavax, Inc. :NVAX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 10, 2017 Capital Cube
May-09-17 03:17PM  Novavax shares jump on news of narrowed first-quarter losses American City Business Journals +15.68%
11:40AM  Novavax, Inc Is Rising Today, but You Should Still Stay Far Away Motley Fool
09:00AM  Edited Transcript of NVAX earnings conference call or presentation 8-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-08-17 04:41PM  Novavax reports 1Q loss Associated Press
04:13PM  Novavax Reports First Quarter 2017 Financial Results GlobeNewswire
04:05PM  Novavax Reports First Quarter 2017 Financial Results GlobeNewswire
11:00AM  Investor Network: Novavax, Inc. to Host Earnings Call Accesswire
May-01-17 04:55PM  No bonuses for Novavax following failed RSV vaccine trial American City Business Journals
04:12PM  ETFs with exposure to Novavax, Inc. : May 1, 2017 Capital Cube
11:13AM  Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017 GlobeNewswire
10:57AM  Novavax to Host Conference Call to Discuss First Quarter 2017 Financial Results on May 8, 2017 GlobeNewswire
Apr-19-17 02:28PM  ETFs with exposure to Novavax, Inc. : April 19, 2017 Capital Cube
Apr-11-17 09:30AM  Biotech Movers Trading Positive Ahead of Market's Open TheStreet.com
Apr-07-17 05:11PM  ETFs with exposure to Novavax, Inc. : April 7, 2017 Capital Cube
09:24AM  Down 12.5%: Is Novavax Stock Too Cheap To Ignore? Motley Fool
Apr-06-17 04:04PM  Valeant, DryShips Dont Escape Thursdays 52-Week Low Club 24/7 Wall St. -12.54%
07:30AM  Today's Research Reports on Biotech Stocks to Watch: Sarepta Therapeutics and Novavax Accesswire
Apr-05-17 04:04PM  Valeant, DryShips Plunge into Wednesdays 52-Week Low Club 24/7 Wall St. -11.21%
10:55AM  The Waiting Game Crushed Novavax, Inc. in March, Sending Shares Down 15% Motley Fool
08:47AM  Implied Volatility Surging for Novavax (NVAX) Stock Options Zacks
Mar-31-17 08:05AM  3 Companies That Might Not Live to See 2020 Motley Fool
Mar-27-17 04:02PM  ETFs with exposure to Novavax, Inc. : March 27, 2017 Capital Cube
09:30AM  Biotech Industry Continues to Provide Investors with Gains in 2017: Today's Reports on Peregrine Pharmaceuticals and Novavax Accesswire
06:55AM  The 6 Most Shorted Nasdaq Stocks 24/7 Wall St.
Mar-21-17 08:22AM  3 Beaten-Up Biotech Stocks: Are They Bargains? Motley Fool -7.58%
Mar-20-17 08:59AM  Novavax, Inc. :NVAX-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
Mar-16-17 09:30AM  Trade Volume Can Speak a Lot About Momentum of a Stock Accesswire
Mar-14-17 02:50PM  Novavax, Inc. :NVAX-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
Mar-09-17 12:40PM  These 5 Stocks Under $10 Could Ignite Soon
07:47AM  These Popular Stocks Could Prove Toxic for Your Portfolio at Motley Fool
Mar-06-17 11:02AM  Why Novavax's Shares Marched Higher in February at Motley Fool
09:30AM  Biotech's Rally in 2017 Gaining Steam After President Trump's Speech: Today's Reports on BioScrip and Novavax Accesswire
Mar-03-17 01:04PM  NOVAVAX INC Financials
Feb-28-17 07:02PM  NOVAVAX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits -7.36%
06:13PM  Here's Why Novavax, Inc.'s Share Price Went Down the Drain at Motley Fool
11:03AM  3 Stocks to Avoid in Biotech at Motley Fool
10:10AM  Novavax: 'We still expect to enjoy the advantage of being the first RSV vaccine' at bizjournals.com
09:45AM  Novavax Stock Spikes on Q4 Results at Investopedia
09:22AM  Biotech Premarket Movers: Cempra, Novavax, Ionis
Feb-27-17 05:26PM  Novavax reports 4Q loss +18.12%
05:06PM  NOVAVAX INC Files SEC form 10-K, Annual Report
04:30PM  Novavax Inc Earnings Call scheduled for 4:30 pm ET today
04:11PM  Novavax Reports Fourth Quarter and Year-End 2016 Financial Results GlobeNewswire
04:05PM  Novavax Reports Fourth Quarter and Year-End 2016 Financial Results GlobeNewswire
07:07AM  Q4 2016 Novavax Inc Earnings Release - After Market Close
Feb-20-17 04:06PM  Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017 GlobeNewswire
04:05PM  Novavax to Host Conference Call to Discuss Fourth Quarter and Year-End 2016 Financial Results on February 27, 2017 GlobeNewswire
Feb-16-17 01:10PM  Better Buy: Novavax, Inc. vs. Inovio Pharmaceuticals at Motley Fool
09:30AM  Biotech Industry Poised for a Breakout in 2017? Today's Reports on Evoke Pharma and Novavax Accesswire
Feb-14-17 08:28AM  Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : February 14, 2017
Feb-03-17 09:22AM  Cluster of Insider Buying at Clinical-Stage Vaccine Company, Massive Insider Selling at Analog Chip Giant, Plus Other Insider Trading at Insider Monkey
Jan-28-17 04:58PM  Can Novavax Stay Ahead of the Competition? at Motley Fool
Jan-27-17 07:53AM  Novavax, Inc. breached its 50 day moving average in a Bearish Manner : NVAX-US : January 27, 2017
Jan-24-17 09:26AM  Biotech Premarket Movers: Amicus Therapeutics, Nantkwest and Organovo
Jan-19-17 05:00PM  Novavax starts new clinical trial in bid to prove failed RSV vaccine at bizjournals.com
04:06PM  Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults GlobeNewswire
04:05PM  Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults GlobeNewswire
Jan-17-17 09:56AM  Better Buy: Novavax, Inc. vs. Roche at Motley Fool
Jan-13-17 08:50AM  In Honor Of Friday The 13th, Here Are Some Of The Unluckiest Trades Of 2016
Jan-11-17 11:10PM  D.C.-area biotech stocks fall on Trump's tough talk on industry at bizjournals.com -5.59%
Jan-10-17 11:01AM  Novavax, Inc. Value Analysis (NASDAQ:NVAX) : January 10, 2017
Jan-09-17 07:18AM  Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : January 9, 2017
Jan-06-17 02:33PM  5 Stocks Setting Up for Big Breakouts
10:10AM  Novavax, Inc. Stock Sank 83% in 2016 -- Could 2017 Be Even Worse? at Motley Fool
Jan-05-17 08:06AM  Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
08:05AM  Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire
06:30AM  Genocea Announces Positive 6-Month Results from GEN-003 Phase 2b Clinical Trial GlobeNewswire
Jan-03-17 02:35PM  ETFs with exposure to Novavax, Inc. : January 3, 2017
Dec-28-16 08:35AM  Are Options Traders Betting on a Big Move in Novavax (NVAX) Stock?
Dec-22-16 09:36AM  2016's Worst Clinical Failures at Motley Fool
Dec-21-16 12:39PM  ETFs with exposure to Novavax, Inc. : December 21, 2016
07:11AM  Novavax, Inc. breached its 50 day moving average in a Bullish Manner : NVAX-US : December 21, 2016
Dec-13-16 11:45AM  Why Novavax (NVAX) Stock Might be a Great Pick
Dec-07-16 05:30AM  Here is What Hedge Funds Think About Novavax, Inc. (NVAX) at Insider Monkey -8.90%
Dec-06-16 04:19PM  Why Novavax Stock Crashed in November at Motley Fool +13.18%
04:06PM  Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference GlobeNewswire
04:05PM  Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference GlobeNewswire
01:19PM  Read This Before You Buy Biotech Stocks at Motley Fool
Dec-05-16 12:25PM  ETFs with exposure to Novavax, Inc. : December 5, 2016
Dec-02-16 01:17PM  The Worst Biotech Stocks of 2016 at Motley Fool +5.08%
Dec-01-16 10:47AM  3 Drug Stocks Investors Shouldn't Touch With a 10-Foot Pole in 2017 at Motley Fool
Nov-30-16 10:18PM  5 Stocks Hedge Funds Are Betting Against Insiders at Insider Monkey
04:06PM  Novavax to Participate in the Citi 2016 Global Healthcare Conference GlobeNewswire
04:05PM  Novavax to Participate in the Citi 2016 Global Healthcare Conference GlobeNewswire
Nov-23-16 01:18PM  ETFs with exposure to Novavax, Inc. : November 23, 2016
Nov-22-16 04:28PM  A Strong Case for Selling Novavax, Inc. Stock at Motley Fool
04:07PM  Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
04:05PM  Novavax to Present at the 28th Annual Piper Jaffray Healthcare Conference GlobeNewswire
Novavax, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of recombinant nanoparticle vaccines and adjuvants. The company develops respiratory syncytial virus fusion protein nanoparticle vaccine candidate for infants via maternal immunization in Phase III development stage; older adults in Phase II development stage; and children six months to five years of age in Phase I development stage. It also develops Ebola GP vaccine in Phase 1 clinical trial; preclinical programs for Zika virus; and seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCMANUS MICHAEL A JRDirectorMay 12Buy0.9720,00019,396277,590May 12 03:24 PM
MCMANUS MICHAEL A JRDirectorMay 11Buy0.8410,0008,400257,590May 11 03:42 PM
PHILLIPS BARCLAY ASVP, Chief Financial OfficerMay 11Buy0.8425,00020,95036,612May 11 10:45 AM
Erck Stanley CPresident and CEOMay 11Buy0.8450,00041,980128,279May 11 10:29 AM
DOUGLAS RICHARDDirectorMay 11Buy0.93200,000185,780550,000May 12 09:59 AM
YOUNG JAMES FDirectorMar 14Sale1.39100,000138,980175,000Mar 16 04:19 PM
Trizzino JohnSVP, Commercial OperationsJan 31Buy1.123,4013,80988,965Feb 02 04:13 PM
Herrmann John A IIISVP, General CounselJan 31Buy1.124,9605,5557,072Feb 02 04:12 PM
PHILLIPS BARCLAY ASVP, Chief Financial OfficerJan 31Buy1.121,6331,82911,612Feb 02 04:10 PM
Glenn Gregory MPresident, R&DDec 07Buy1.451,0001,4464,427Dec 07 04:29 PM
Trizzino JohnSVP, Commercial OperationsSep 22Buy2.1746,00099,82085,564Sep 23 05:21 PM
DOUGLAS RICHARDDirectorSep 21Buy1.72100,000172,010350,000Sep 22 04:26 PM
MCMANUS MICHAEL A JRDirectorSep 21Buy1.6130,00048,297247,590Sep 22 04:24 PM
Glenn Gregory MPresident, R&DSep 21Buy1.651,0001,6493,427Sep 22 04:20 PM
BOUDREAUX GAILDirectorSep 20Buy1.45100,000144,850200,000Sep 21 04:21 PM
PHILLIPS BARCLAY ASVP, Chief Financial OfficerJul 31Buy4.294221,8109,979Aug 02 06:17 PM
EVANS GARY CDirectorJun 06Sale6.5018,998123,487321,979Jun 07 04:14 PM